1. Bedrosian I, Somerfield MR, Achatz MI, Boughey JC, Curigliano G, Friedman S, et al. Germline testing in patients with breast cancer: ASCO-SSO guideline. J Clin Oncol. 2024. https://doi.org/10.1200/JCO.23.02225.
2. American Society of Breast Surgeons (ASBrS). Retrieved xxxx at https://www.breastsurgeons.org/docs/statements/Consensus-Guideline-on-Genetic-Testing-for-Hereditary-Breast-Cancer.pdf.
3. National Comprehensive Cancer Network (NCCN) guidelines. Genetic/familial high-risk assessment: breast, ovarian and pancreatic. Version 2.2024. Retrieved 19 December 2023 at https://www.nccn.org/professionals/physician_gls/pdf/genetics_bop.pdf.
4. Hereditary Cancer Testing Eligibility Criteria: Version 3. Cancer Care Ontario. Ontario Health (2022). HCTEligibilityCriteriaV3_0.pdf. Retrieved from December 19, 2023. https://www.cancercareontario.ca/en/guidelines-advice/types-of-cancer/70161
5. Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, ESMO Guidelines Committee, et al. Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline. Ann Oncol. 2023;34:33–47. https://doi.org/10.1016/j.annonc.2022.10.004.